Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Nov 1;379(18):1745-1753.
doi: 10.1056/NEJMoa1804498. Epub 2018 Oct 17.

Genomic Analysis of Lassa Virus during an Increase in Cases in Nigeria in 2018

Affiliations

Genomic Analysis of Lassa Virus during an Increase in Cases in Nigeria in 2018

Katherine J Siddle et al. N Engl J Med. .

Abstract

During 2018, an unusual increase in Lassa fever cases occurred in Nigeria, raising concern among national and international public health agencies. We analyzed 220 Lassa virus genomes from infected patients, including 129 from the 2017-2018 transmission season, to understand the viral populations underpinning the increase. A total of 14 initial genomes from 2018 samples were generated at Redeemer's University in Nigeria, and the findings were shared with the Nigerian Center for Disease Control in real time. We found that the increase in cases was not attributable to a particular Lassa virus strain or sustained by human-to-human transmission. Instead, the data were consistent with ongoing cross-species transmission from local rodent populations. Phylogenetic analysis also revealed extensive viral diversity that was structured according to geography, with major rivers appearing to act as barriers to migration of the rodent reservoir.

PubMed Disclaimer

Figures

Figure 1: Incidence of Lassa virus in Nigeria in recent years.
Figure 1: Incidence of Lassa virus in Nigeria in recent years.
a) Number of clinically suspected Lassa fever cases (blue) and RT-qPCR-positive cases (orange) tested at ISTH monthly from January 2012 to February 2018. Counts are those reported by ISTH. Gray shading denotes dry season months in Nigeria, when Lassa cases are typically highest. b) Samples processed at ISTH from January 1 to March 13, 2018. Outcome data, where available, are up to date as of March 22.
Figure 2. Distribution of Lassa virus genetic diversity in Nigeria.
Figure 2. Distribution of Lassa virus genetic diversity in Nigeria.
a) Maximum likelihood phylogenetic tree of the S segment of the Lassa virus genome. The tree incorporates the 77 new sequences presented here alongside 193 previously published sequences from Nigeria and the Mano River Union (in gray). The 77 new samples are coloured by geographic region in which the patient resides. Samples from 2018 are in bold. b) Map of Nigeria highlighting the states from which the 77 new sequences originate and the number of samples from each state. Colours are the same as in A. Kogi state, at the intersection of the 2 rivers, is shown in striped purple reflecting the clustering of the single sequenced sample from this state with others from the southwest region in A. The location of Irrua Specialist Teaching Hospital is marked in yellow.

Similar articles

  • Arenavirus Diversity and Phylogeography of Mastomys natalensis Rodents, Nigeria.
    Olayemi A, Obadare A, Oyeyiola A, Igbokwe J, Fasogbon A, Igbahenah F, Ortsega D, Asogun D, Umeh P, Vakkai I, Abejegah C, Pahlman M, Becker-Ziaja B, Günther S, Fichet-Calvet E. Olayemi A, et al. Emerg Infect Dis. 2016 Apr;22(4):694-7. doi: 10.3201/eid2204.150155. Emerg Infect Dis. 2016. PMID: 26982388 Free PMC article.
  • Metagenomic sequencing at the epicenter of the Nigeria 2018 Lassa fever outbreak.
    Kafetzopoulou LE, Pullan ST, Lemey P, Suchard MA, Ehichioya DU, Pahlmann M, Thielebein A, Hinzmann J, Oestereich L, Wozniak DM, Efthymiadis K, Schachten D, Koenig F, Matjeschk J, Lorenzen S, Lumley S, Ighodalo Y, Adomeh DI, Olokor T, Omomoh E, Omiunu R, Agbukor J, Ebo B, Aiyepada J, Ebhodaghe P, Osiemi B, Ehikhametalor S, Akhilomen P, Airende M, Esumeh R, Muoebonam E, Giwa R, Ekanem A, Igenegbale G, Odigie G, Okonofua G, Enigbe R, Oyakhilome J, Yerumoh EO, Odia I, Aire C, Okonofua M, Atafo R, Tobin E, Asogun D, Akpede N, Okokhere PO, Rafiu MO, Iraoyah KO, Iruolagbe CO, Akhideno P, Erameh C, Akpede G, Isibor E, Naidoo D, Hewson R, Hiscox JA, Vipond R, Carroll MW, Ihekweazu C, Formenty P, Okogbenin S, Ogbaini-Emovon E, Günther S, Duraffour S. Kafetzopoulou LE, et al. Science. 2019 Jan 4;363(6422):74-77. doi: 10.1126/science.aau9343. Science. 2019. PMID: 30606844 Free PMC article.
  • Phylogeography of Lassa Virus in Nigeria.
    Ehichioya DU, Dellicour S, Pahlmann M, Rieger T, Oestereich L, Becker-Ziaja B, Cadar D, Ighodalo Y, Olokor T, Omomoh E, Oyakhilome J, Omiunu R, Agbukor J, Ebo B, Aiyepada J, Ebhodaghe P, Osiemi B, Ehikhametalor S, Akhilomen P, Airende M, Esumeh R, Muoebonam E, Giwa R, Ekanem A, Igenegbale G, Odigie G, Okonofua G, Enigbe R, Omonegho Yerumoh E, Pallasch E, Bockholt S, Kafetzopoulou LE, Duraffour S, Okokhere PO, Akpede GO, Okogbenin SA, Odia I, Aire C, Akpede N, Tobin E, Ogbaini-Emovon E, Lemey P, Adomeh DI, Asogun DA, Günther S. Ehichioya DU, et al. J Virol. 2019 Oct 15;93(21):e00929-19. doi: 10.1128/JVI.00929-19. Print 2019 Nov 1. J Virol. 2019. PMID: 31413134 Free PMC article.
  • Systematics, Ecology, and Host Switching: Attributes Affecting Emergence of the Lassa Virus in Rodents across Western Africa.
    Olayemi A, Fichet-Calvet E. Olayemi A, et al. Viruses. 2020 Mar 14;12(3):312. doi: 10.3390/v12030312. Viruses. 2020. PMID: 32183319 Free PMC article. Review.
  • A short history of Lassa fever: the first 10-15 years after discovery.
    Monath TP. Monath TP. Curr Opin Virol. 2019 Aug;37:77-83. doi: 10.1016/j.coviro.2019.06.005. Epub 2019 Jul 16. Curr Opin Virol. 2019. PMID: 31323506 Review.

Cited by

References

    1. Geisbert TW. Predicting outcome and improving treatment for Lassa fever. Lancet Infect Dis 2018;18(6):594–5. - PubMed
    1. The Lancet Infectious Diseases. Lassa fever and global health security. Lancet Infect Dis 2018;18(4):357. - PMC - PubMed
    1. WHO. AN R&D BLUEPRINT FOR ACTION TO PREVENT EPIDEMICS. 2016.
    1. WHO. 2018 Annual review of diseases prioritized under the R&D Blueprint [Internet]. 2018. Available from: http://www.who.int/emergencies/diseases/2018prioritization-report.pdf
    1. McCormick JB, King IJ, Webb PA, et al. Lassa fever. Effective therapy with ribavirin. N Engl J Med 1986;314(1):20–6. - PubMed

Publication types

MeSH terms